Abstract
Physicians and patients have been frustrated by the lack of reliable information on unconventional therapies. To help fill this gap in the area of breast cancer therapy, the Canadian Breast Cancer Research Initiative formed a task force to advise it on how best to promote research into unconventional therapies. As part of the work of the task force, a review of the available literature was carried out for each of the following products: Essiac, green tea, Iscador, hydrazine sulfate, vitamins A, C and E, and 714-X. The first article in this series on unconventional therapies for cancer describes the methodology used to obtain and evaluate the information and provides a summary of the findings on Essiac. Subsequent articles will cover the other products. For most of the products reviewed, there has been some indication of possible benefit but no definitive evidence. Innovative and collaborative research needed to meet the information needs of growing numbers of patients and their physicians is now being sponsored by the Canadian Breast Cancer Research Initiative. Open communication between patients and physicians is also necessary for the maintenance of an appropriate therapeutic partnership and for the identification and control of side effects. The Ontario Division of the Canadian Cancer Society, a partner in the Canadian Breast Cancer Research Initiative, supported the preparation of a patient-information piece on unconventional therapies to accompany the series. This item will assist patients who are considering such therapies and will promote open communication between patients and their physicians.
Full Text
The Full Text of this article is available as a PDF (181.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BELKIN M., FITZGERALD D. B. Tumor-damaging capacity of plant materials. I. Plants used as cathartics. J Natl Cancer Inst. 1952 Aug;13(1):139–155. [PubMed] [Google Scholar]
- Dombrádi C. A., Földeák S. Screening report on the antitumor activity of purified Arctium Lappa extracts. Tumori. 1966 May-Jun;52(3):173–175. doi: 10.1177/030089166605200302. [DOI] [PubMed] [Google Scholar]
- Driscoll J. S., Hazard G. F., Jr, Wood H. B., Jr, Goldin A. Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother Rep 2. 1974 Apr;4(2):1–362. [PubMed] [Google Scholar]
- Gray C. Laetrile: Canada's legal position firm but pressure in the South grows. Can Med Assoc J. 1977 Nov 5;117(9):1068–1074. [PMC free article] [PubMed] [Google Scholar]
- Kato A., Ando K., Tamura G., Arima K. Effects of some fatty acid esters on the viability and transplantability of Ehrlich ascites tumor cells. Cancer Res. 1971 May;31(5):501–504. [PubMed] [Google Scholar]
- Kupchan S. M., Karim A. Tumor inhibitors. 114. Aloe emodin: antileukemic principle isolated from Rhamnus frangula L. Lloydia. 1976 Jul-Aug;39(4):223–224. [PubMed] [Google Scholar]
- Lee H., Tsai S. J. Effect of emodin on cooked-food mutagen activation. Food Chem Toxicol. 1991 Nov;29(11):765–770. doi: 10.1016/0278-6915(91)90185-a. [DOI] [PubMed] [Google Scholar]
- Masuda T., Ueno Y. Microsomal transformation of emodin into a direct mutagen. Mutat Res. 1984 Feb;125(2):135–144. doi: 10.1016/0027-5107(84)90065-4. [DOI] [PubMed] [Google Scholar]
- Miyamoto K., Nomura M., Sasakura M., Matsui E., Koshiura R., Murayama T., Furukawa T., Hatano T., Yoshida T., Okuda T. Antitumor activity of oenothein B, a unique macrocyclic ellagitannin. Jpn J Cancer Res. 1993 Jan;84(1):99–103. doi: 10.1111/j.1349-7006.1993.tb02790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morita H., Umeda M., Masuda T., Ueno Y. Cytotoxic and mutagenic effects of emodin on cultured mouse carcinoma FM3A cells. Mutat Res. 1988 Feb;204(2):329–332. doi: 10.1016/0165-1218(88)90107-3. [DOI] [PubMed] [Google Scholar]
- Rhoads P. M., Tong T. G., Banner W., Jr, Anderson R. Anticholinergic poisonings associated with commercial burdock root tea. J Toxicol Clin Toxicol. 1984;22(6):581–584. doi: 10.3109/15563658408992587. [DOI] [PubMed] [Google Scholar]
- Wong C. K., Leung K. N., Fung K. P., Choy Y. M. Immunomodulatory and anti-tumour polysaccharides from medicinal plants. J Int Med Res. 1994 Nov-Dec;22(6):299–312. doi: 10.1177/030006059402200601. [DOI] [PubMed] [Google Scholar]
- Yanagihara K., Ito A., Toge T., Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993 Dec 1;53(23):5815–5821. [PubMed] [Google Scholar]